Cecile C. Balagtas

591 total citations
7 papers, 419 citations indexed

About

Cecile C. Balagtas is a scholar working on Pulmonary and Respiratory Medicine, Endocrinology, Diabetes and Metabolism and Pharmacology. According to data from OpenAlex, Cecile C. Balagtas has authored 7 papers receiving a total of 419 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 3 papers in Endocrinology, Diabetes and Metabolism and 1 paper in Pharmacology. Recurrent topics in Cecile C. Balagtas's work include Pulmonary Hypertension Research and Treatments (3 papers), Inhalation and Respiratory Drug Delivery (3 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (2 papers). Cecile C. Balagtas is often cited by papers focused on Pulmonary Hypertension Research and Treatments (3 papers), Inhalation and Respiratory Drug Delivery (3 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (2 papers). Cecile C. Balagtas collaborates with scholars based in United States, Sweden and Czechia. Cecile C. Balagtas's co-authors include William Landschulz, R. Gelfand, Jay S. Skyler, William T. Cefalu, IONE A. KOURIDES, Baldvin Jónsson, N. Cheruvu, Christine M. Pierce, Robin H. Steinhorn and Stefania Lamon‐Fava and has published in prestigious journals such as The Lancet, Circulation and Annals of Internal Medicine.

In The Last Decade

Cecile C. Balagtas

7 papers receiving 384 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cecile C. Balagtas United States	6	249	208	112	81	46	7	419
S. Bott Germany	9	121 0.5×	452 2.2×	167 1.5×	68 0.8×	106 2.3×	11	590
Tricia Santos Cavaiola United States	10	61 0.2×	243 1.2×	123 1.1×	20 0.2×	24 0.5×	14	343
L Heinemann Germany	9	95 0.4×	603 2.9×	338 3.0×	42 0.5×	36 0.8×	28	746
P A Jenkins United Kingdom	12	62 0.2×	121 0.6×	60 0.5×	51 0.6×	85 1.8×	27	358
Daniel A. Nadeau United States	9	14 0.1×	175 0.8×	95 0.8×	16 0.2×	44 1.0×	13	318
VP Carnielli Italy	8	84 0.3×	25 0.1×	86 0.8×	35 0.4×	34 0.7×	18	265
Melanie M. van Riemsdijk Netherlands	10	137 0.6×	27 0.1×	49 0.4×	31 0.4×	4 0.1×	13	371
William H. Meetze United States	8	192 0.8×	73 0.4×	80 0.7×	99 1.2×	63 1.4×	11	471
Sibylle Dellweg Germany	11	11 0.0×	430 2.1×	268 2.4×	22 0.3×	58 1.3×	15	604
Mikko Hallman Finland	13	268 1.1×	20 0.1×	68 0.6×	118 1.5×	28 0.6×	15	428

Countries citing papers authored by Cecile C. Balagtas

Since Specialization

Citations

This map shows the geographic impact of Cecile C. Balagtas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cecile C. Balagtas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cecile C. Balagtas more than expected).

Fields of papers citing papers by Cecile C. Balagtas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cecile C. Balagtas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cecile C. Balagtas. The network helps show where Cecile C. Balagtas may publish in the future.

Co-authorship network of co-authors of Cecile C. Balagtas

This figure shows the co-authorship network connecting the top 25 collaborators of Cecile C. Balagtas. A scholar is included among the top collaborators of Cecile C. Balagtas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cecile C. Balagtas. Cecile C. Balagtas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

Hoeper, Marius M., Ralf Ewert, Pavel Jansa, et al.. (2024). Randomized, Multicenter Study to Assess the Effects of Different Doses of Sildenafil on Mortality in Adults With Pulmonary Arterial Hypertension. Circulation. 149(25). 1949–1959. 7 indexed citations

Pierce, Christine M., et al.. (2021). Efficacy and Safety of IV Sildenafil in the Treatment of Newborn Infants with, or at Risk of, Persistent Pulmonary Hypertension of the Newborn (PPHN): A Multicenter, Randomized, Placebo-Controlled Trial. The Journal of Pediatrics. 237. 154–161.e3. 19 indexed citations

Russell, Stuart D., Maurice Beghetti, Ronald J. Oudiz, et al.. (2019). Effects of oral sildenafil on exercise capacity in children with pulmonary arterial hypertension: a randomised trial. Open Heart. 6(2). e001149–e001149. 2 indexed citations

Skyler, Jay S., William T. Cefalu, IONE A. KOURIDES, et al.. (2001). Efficacy of inhaled human insulin in type 1 diabetes mellitus: a randomised proof-of-concept study. The Lancet. 357(9253). 331–335. 215 indexed citations

Cefalu, William T., Jay S. Skyler, IONE A. KOURIDES, et al.. (2001). Inhaled Human Insulin Treatment in Patients with Type 2 Diabetes Mellitus. Annals of Internal Medicine. 134(3). 203–207. 152 indexed citations

Balagtas, Cecile C., et al.. (2000). Sustained efficacy and pulmonary safety of inhaled insulin during 2 years of outpatient therapy. Diabetes Research and Clinical Practice. 50. 73–73. 12 indexed citations

Schaefer, Ernst J., Stefania Lamon‐Fava, Thomas Cole, et al.. (1996). Effects of regular and extended-release gemfibrozil on plasma lipoproteins and apolipoproteins in hypercholesterolemic patients with decreased HDL cholesterol levels. Atherosclerosis. 127(1). 113–122. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact